INDEPENDENCE Spacer for Lumbar Fusion
Circumferential Lumbar Spinal Fusion for Treatment of Degenerative Disc Disease: A Prospective, Non-Randomized Clinical Study
研究概览
详细说明
A total of thirty subjects will be enrolled at Scott & White Healthcare. The INDEPENDENCE spacer will be filled with autogenous bone graft material. The devices subject to this Agreement have received 510(k) clearance from the FDA for the indications specified in this Agreement.
Patients will be followed for 2 years with evaluations at the following time intervals: preoperatively (within 2 months of surgery) and postoperatively at 6 weeks, 3 months, 6 months, 12 months, and 24 months.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Texas
-
Temple、Texas、美国、76508
- Scott & White Healthcare
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
• Objective evidence of degenerative disc disease at 1 or 2 level(s) between L2 and S1 with degeneration confirmed by patient history and radiographic examination
- Experience pain, functional deficit and/or neurological deficit for a minimum of six months
- Unresponsiveness to documented non-surgical treatment modalities for a minimum of six months and/or presentation with progressive symptoms of nerve root or spinal cord compression prior to enrollment
- At least 18 years of age and maximum 65 years of age
- Ability to provide Informed Consent for study participation and to return for all follow-up visits
Exclusion Criteria:
• Presence of systemic or localized infection at the site of surgery
- More than 2 levels to be instrumented
- Previous fusion attempt at the involved level(s)
- More than three previous open, posterior, lumbar spinal surgical procedures at the involved level(s)
- Trauma at the level(s) to be fused
- More than grade 1 spondylolisthesis
- Previous documentation of osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
- Diagnosis of a condition or requires postoperative medication(s), which may interfere with bony/soft tissue healing
- Presence of a disease entity or condition which totally precludes possibility of bony fusion (e.g. metastatic cancer, HIV, long term use of steroids, etc.)
- Immunosuppressive disorder
- Pregnant or interested in becoming pregnant during the duration of the study
- History of substance abuse (drugs or alcohol)
- Any known allergy to a metal alloy
- Mentally incompetent or prisoner
- Currently a participant in another study
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Radiographic fusion evaluation
大体时间:2 years
|
Anterior Posterior / Lateral, Flexion-Extension X-rays at every timepoint will be evaluated for signs of fusion, pseudoarthrosis and implant subsidence or migration
|
2 years
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Patient Self- Assessment for pain scores
大体时间:2 years
|
VAS questionnaires to be completed at every follow-up timepoint
|
2 years
|
|
Patient Satisfaction
大体时间:2 years
|
Questionnaire to be completed at every follow-up timepoint
|
2 years
|
合作者和调查者
调查人员
- 首席研究员:Christopher Chaput, MD、Scott & White Healthcare
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.